levofloxacin has been researched along with atracurium in 5 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (atracurium) | Trials (atracurium) | Recent Studies (post-2010) (atracurium) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 1,947 | 561 | 254 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bridts, CH; Campillo-Davo, D; De Puysseleyr, LP; Ebo, DG; Elst, J; Faber, MA; Hagendorens, MM; Lion, E; Maurer, M; Mertens, C; Sabato, V; van der Poorten, MM; Van Gasse, AL; Van Houdt, M; Van Tendeloo, VF | 1 |
1 review(s) available for levofloxacin and atracurium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for levofloxacin and atracurium
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Topics: Anaphylaxis; Anti-Bacterial Agents; Atracurium; Calcium Signaling; Cell Degranulation; Cells, Cultured; Ciprofloxacin; Drug Hypersensitivity; Humans; Immunoglobulin E; Levofloxacin; Mast Cells; Nerve Tissue Proteins; Neuromuscular Nondepolarizing Agents; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Rocuronium; Time Factors | 2021 |